Heron Therapeutics | HRTX - Market Capitalization


Heron Therapeutics reported $49M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 7.43B 629M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amarin USD 290M 51M Dec/2025
ANI Pharmaceuticals USD 1.46B 206M Nov/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 5.87B 5.63B Nov/2026
Eisai JPY 1.41T 5.37B Nov/2026
Emergent BioSolutions USD 125M 51M Dec/2023
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 24.93B 1.82B Sep/2026
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neurocrine Biosciences USD 16.38B 1.96B Nov/2026
Pacira USD 1.7B 696M Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Veracyte USD 4.12B 414M Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026